2025 · 2nd Quarter (Apr 1 - June 30)
Filed by VAN SCOYOC ASSOCIATES.
Open official filingSource-reported fields
Literal source text
Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, FY2026
Literal federal measure citations: H.R.4016
Medical research issues and Neurofibromatosis provisions, as follows: Public Law 119-4, Full-Year Continuing Appropriations and Extensions Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026
Literal federal measure citations: H.R.4016
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.
